KUMAR NEIL (See Remarks) sold 10.7% of their position (28.05K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $2.00M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/23/2026ACC: 0001470831-26-000214
DirectorOfficer· See Remarks
Since Jun 2019
-28.05K
Net shares
Net seller
$2.00M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
28.05K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−18.92K
Price / share
$71.03
Trade value
$1.34M
% of position
7.2%
2/19/2026
262.50K→243.58K
Common Stock
Direct
Shares
−8.53K
Price / share
$72.08
Trade value
$614.70K
% of position
3.5%
2/19/2026
243.58K→235.05K
Common Stock
Direct
Shares
−602.00
Price / share
$72.80
Trade value
$43.83K
% of position
0.3%
2/19/2026
235.05K→234.45K
Total
Net shares
−28.05K
Net value
-$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/19/2026 | S · Sale | −18.92K | $71.03 | $1.34M | 7.2% | 262.50K | 243.58K |
| Common Stock Direct | 2/19/2026 | S · Sale | −8.53K | $72.08 | $614.70K | 3.5% | 243.58K | 235.05K |
| Common Stock Direct | 2/19/2026 | S · Sale | −602.00 | $72.80 | $43.83K | 0.3% | 235.05K | 234.45K |
| Total | −28.05K | -$2M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned4.48M
Common Stock
IndirectShares owned675.69K
Total
5.15M indirect5.15M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.48M | Indirect |
| Common Stock | 675.69K | Indirect |
| Total | 5.15M | 5.15M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported